Tolterodine tartrate and Panic disorder - a phase IV clinical study of FDA data

Summary:

Panic disorder is reported as a side effect among people who take Tolterodine tartrate (tolterodine tartrate), especially for people who are female, 40-49 old, also take Calcium, and have Osteoporosis.

The phase IV clinical study analyzes which people have Panic disorder when taking Tolterodine tartrate. It is created by eHealthMe based on reports of 3,666 people who have side effects when taking Tolterodine tartrate from the FDA, and is updated regularly.

What is Tolterodine tartrate?

Tolterodine tartrate has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 3,694 Tolterodine tartrate users. Check the latest studies of Tolterodine tartrate.

What is Panic disorder?

Panic disorder is found to be associated with 1,668 drugs and 2,055 conditions by eHealthMe. Check the latest studies of Panic disorder.

On Jul, 10, 2026

3,666 people reported to have side effects when taking Tolterodine tartrate.
Among them, 15 people (0.41%) have Panic disorder.

Could Tolterodine tartrate cause Panic disorder?

Among these 15 people:

What is the gender of people who have Panic disorder when taking Tolterodine tartrate? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Panic disorder when taking Tolterodine tartrate? *

What are other drugs people take besides Tolterodine tartrate? *

What are other side effects people have besides Panic disorder? *

Stress And Anxiety: 10 people, 66.67%
Depression: 9 people, 60.00%
Chest Pain: 9 people, 60.00%
Insomnia (sleeplessness): 9 people, 60.00%
Constipation: 9 people, 60.00%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 60.00%
Gait Disturbance: 8 people, 53.33%
Nausea (feeling of having an urge to vomit): 8 people, 53.33%
Migraine (headache): 8 people, 53.33%
Joint Pain: 8 people, 53.33%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 46.67%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 5 people, 33.33%
Sleep Disorder: 2 people, 13.33%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 6.67%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 6.67%
Arrhythmias (irregular heartbeat): 1 person, 6.67%
Asthma: 1 person, 6.67%
Back Pain: 1 person, 6.67%
Belching (release of gas from the digestive tract): 1 person, 6.67%
Blood Pressure Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tolterodine tartrate and have Panic disorder?

- Check whether Panic disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tolterodine tartrate:

Tolterodine tartrate (3,694 reports)

Panic disorder treatments and more:

Panic disorder (65,704 reports)

Browse all side effects of Tolterodine tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic disorder:

Panic disorder (1,668 drugs)

Browse all the conditions that are associated with Panic disorder:

Panic disorder (2,055 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Tolterodine tartrate) and Tolterodine tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.